CRP and Hyperglycemia: Linear discriminant analysis (LDA) was used to develop a glycemic prediction model comprising six clinical parameters out of which five were inflammatory markers (CRP, WBC, Platelet, NLR, PLR), where CRP is an indicator of chronic inflammation and one was glycemic indicator (HbA1c or FBG) to differentiate between different states of glycemia (hyperglycemia, borderline hyperglycemia, and normoglycemia).